Discontinuation of Alprazolam after successful treatment of panic disorder: a naturalistic follow-up study
dc.contributor.author | Abelson, James L. | en_US |
dc.contributor.author | Curtis, George C. | en_US |
dc.date.accessioned | 2006-04-10T15:51:31Z | |
dc.date.available | 2006-04-10T15:51:31Z | |
dc.date.issued | 1993 | en_US |
dc.identifier.citation | Abelson, James L., Curtis, George C. (1993)."Discontinuation of Alprazolam after successful treatment of panic disorder: a naturalistic follow-up study." Journal of Anxiety Disorders 7(2): 107-117. <http://hdl.handle.net/2027.42/30929> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6VDK-4608TSY-X/2/a8d22b26c2b2497cd71787ccdf5fff94 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/30929 | |
dc.description.abstract | Low rates of benzodiazepine discontinuation have been seen in long-term outcome studies of alprazolam-treated panic disorder. Discontinuation studies reveal high rates of relapse when alprazolam is stopped. Available data may lack relevance to clinical practice, however, because drug taper rates are often more rapid than those used in many clinical settings. In order to obtain naturalistic data on the long-term course of alprazolam treatment of panic, we obtained follow-up data on 18 of 20 patients who had been enrolled one to two years earlier in a study of alprazolam effects on hypothalamic-pituitary-adrenal (HPA) axis functioning. The HPA protocol provided measures of symptom severity, biological markers, and short-term treatment response (12 weeks). Routine clinical care was then provided, with dosage adjustments dictated by individual clinical needs. The follow-up study repeated clinical measures at a mean of 21 months after initiation of treatment. Alprazolam was discontinued in 78% of patients. Relapse occured in 36% of these. At follow-up, 61% were medication-free. Only 28% were on a benzodiazepine. The four patients remaining on alprazolam were on reduced doses and had maintained clinical gains. HPA axis activity did not predict dose or outcome. Factors related to successful alprazolam discontinuation are discussed. | en_US |
dc.format.extent | 813188 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Discontinuation of Alprazolam after successful treatment of panic disorder: a naturalistic follow-up study | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Social Work | en_US |
dc.subject.hlbsecondlevel | Psychology | en_US |
dc.subject.hlbtoplevel | Social Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Michigan, USA | en_US |
dc.contributor.affiliationum | University of Michigan, Michigan, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/30929/1/0000599.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0887-6185(93)90009-A | en_US |
dc.identifier.source | Journal of Anxiety Disorders | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.